Loading clinical trials...
Loading clinical trials...
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
Conditions
Interventions
[18F]Fluortriopride
Locations
1
United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
January 1, 2015
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
September 2, 2025
NCT06716502
NCT07310264
NCT06290258
NCT00090662
NCT07483606
NCT07310901
Lead Sponsor
University of Pennsylvania
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions